Open access · OA
via OpenAlex
Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Audrey Cras, Dominique Farge, Thierry Carmoi, Jean‐Jacques Lataillade, Dan Wang, Lingyun Sun
Arthritis Research & Therapy · 2015 · ▲ 84 citations
Abstract
Current systemic therapies are rarely curative for patients with severe life-threatening forms of autoimmune diseases (ADs). During the past 15 years, autologous hematopoietic stem cell transplantation has been demonstrated to cure some patients with severe AD refractory to all other available therapies. As a consequence, ADs such as lupus and scleroderma have become an emerging indication for cell therapy. Multipotent mesenchymal stem cells (MSCs), isolated from bone marrow and other sites, display specific immunomodulation and anti-inflammatory properties and appear as ideal tools to treat such diseases. The present update aims at summarizing recent knowledge acquired in the field of MSC-based therapies for lupus and scleroderma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13075-015-0819-7
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Cras, A., Farge, D., Carmoi, T., Lataillade, J., Wang, D., & Sun, L. (2015). Update on mesenchymal stem cell-based therapy in lupus and scleroderma. <em>Arthritis Research & Therapy</em>. https://doi.org/10.1186/s13075-015-0819-7
Vancouver
Cras A, Farge D, Carmoi T, Lataillade J, Wang D, Sun L. Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Research & Therapy. 2015. doi:10.1186/s13075-015-0819-7.
BibTeX
@article{audrey2015Update,
title = {Update on mesenchymal stem cell-based therapy in lupus and scleroderma},
author = {Audrey Cras and Dominique Farge and Thierry Carmoi and Jean‐Jacques Lataillade and Dan Wang and Lingyun Sun},
journal = {Arthritis Research & Therapy},
year = {2015},
doi = {10.1186/s13075-015-0819-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2023
Open access · CC-BY
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases
Stem Cell Research & Therapy 2024
Open access · CC-BY
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
Circulation 2014
Citation only
Abstract 19177: Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients
Korean journal of family medicine 2025
Open access · OA
Systemic aging delay and anti-aging therapy using allogeneic stem cells.
Stem Cells 2003
Citation only
Searching for Alternative Sources of Postnatal Human Mesenchymal Stem Cells: Candidate MSC‐Like Cells from Umbilical Cord
Cells 2021
Open access · CC-BY